FDA Clearance Tracker · K242981
Atellica IM Thyroglobulin (Tg)
Last checked: Nov 20, 2026Latest source record: Jun 20, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Jun 20, 2025
Substantially Equivalent
Time to decision
267 days
Received Sep 26, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K242981
- Device name
- Atellica IM Thyroglobulin (Tg)
- Applicant
- Siemens Healthcare Diagnostics, Inc.
- Applicant location
- Tarrytown, NY
- Received
- Sep 26, 2024
- Decided
- Jun 20, 2025
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- System, Test, Thyroglobulin (MSW)
- Device class
- Class II
- Regulation
- 21 CFR 866.6010
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code MSW. The earliest in FDA's data is K982468, decided Mar 12, 1999.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K242981
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Siemens Healthcare Diagnostics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260674 · Decided Nov 6, 2026 · 249 days after receipt
Device type: System, Test, Vitamin D (MRG) · Laboratory Medicine & Pathology
- Atellica IM CA 19-9 II510(k)
K253528 · Decided Aug 10, 2026 · 270 days after receipt
Device type: System, Test, Carbohydrate Antigen (Ca19-9), For Monitoring And Management Of Pancreatic Cancer (NIG) · Laboratory Medicine & Pathology
K261364 · Decided Jul 24, 2026 · 88 days after receipt
Device type: Colorimetry, Acetaminophen (LDP) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.